Conference abstractPublished 19 Mar 2018
Photobiomodulation and photobio-inhibition of cancer stem cells and use of photodynamic therapy as possible therapeutic modality
University of Johannesburg, South Africa
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cancer is a global burden, which have prompted extensive research into cancer prevention and treatment for many decades. Scientific studies have shown that a subset of cells within a tumour, called cancer stem cells (CSCs), can initiate tumour genesis. Low-intensity laser irradiation (LILI) has been applied in the treatment of numerous diseases and pathological conditions. Photobiomodulation has been shown to stimulate proliferation of cells, capillary growth, and cellular metabolism as observed by adenosine triphosphate activation. It has been shown, by using different fluences and wavelengths, LILI, can either stimulate or inhibit cellular functions. Cancer research is highly focused on improving current cancer treatments. One method of targeted cancer therapy is Photodynamic therapy (PDT), LILI, along with a photochemical compound, is used. When implementing a mechanism by which CSCs are targeted, LILI might pose as a viable treatment option. Studies have shown that using high fluences of LILI cell death may be induced in normal and neoplastic cells. In our work, lung and breast CSCs were isolated using stem cell markers and irradiated at wavelengths of 636, 825 and 1060 nm at fluences ranging from 5 J/cm2 to 40 J/cm2. Post irradiation biochemical assays were conducted to monitor cellular responses including; proliferation and cytotoxicity, after 24 hours incubation. Results indicate that LILI, when treating CSCs, can induce either a bio-stimulatory or bio-inhibitory effect depending on the wavelength and fluence used. This study indicated successful cell damage in CSCs when using HF-LILI, as well as, stimulation of ATP production, when using lower fluences of LILI.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Heidi Abrahamse”